InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Szela Mary T. Insider active across 3 companies, notably Prometheus Biosciences, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 5 buys · 1 sell. Total volume traded: €334k. Activity tracked since 19 May 2023. The latest transaction was disclosed on 30 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Szela Mary T is a declarant linked to TriSalus Life Sciences, Inc. (CEO and President), Absci Corp (Director), and Prometheus Biosciences, Inc. (Director). She has 13 filings in total, and across the sampled recent filings from 2023-05-19 to 2026-07-06, buys amount to EUR 318157 and sells to EUR 15501. The modal transaction nature is Attribution.